Please login to the form below

Not currently logged in

New EMG leadership announced

The European Medicines Group has elected Matthew Speers as chair and Steve Turley as vice chair

Matthew Speers has been elected chair of the European Medicines Group (EMG), which represents the UK voice of research-driven pharmaceutical companies headquartered in continental Europe.

Speers is managing director of UCB UK and Ireland, a position he has held since March 2008. In his new capacity as chair, Speers will be supported by Steve Turley, managing director, Lundbeck, who was elected vice chair.

Commenting on his appointment, Speers said: "Despite the tremendous advances in research and development we continue to face considerable market access challenges in the UK with uptake of innovative medicines still lagging significantly behind Europe.

"I am delighted to have been elected to lead the EMG and to continue the work we have undertaken to ensure that all UK citizens have timely access to appropriate, innovative medicines taking other countries in Europe as our benchmark."

Speers succeeds Nigel Brooksby (sanofi-aventis) who led the group for two years.

25th August 2010


Featured jobs

Subscribe to our email news alerts


Add my company

Transforming healthcare through effective collaboration. Making work to feel proud of.

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....